Accelerating Introduction of New Vaccines: Barriers to Introduction and Lessons Learned From the Recent Haemophilus influenzae type b Vaccine Experience
This article, from the Philosophical Transactions of the Royal Society B, examines recent efforts to accelerate the introduction of Haemophilus influenzae type b (Hib) vaccines in developing countries, which resulted in a significant surge in vaccine adoption by these countries. The author states that this experience provides a strategy for new vaccine adoption with a useful model to help accelerate the uptake of other life-saving vaccines. This strategy focuses on three major areas: communications to increase awareness about the various factors needed for evidence-based decisions that meet a country's health goals; research activities to answer key questions that support vaccine introduction and long-term program sustainability; and coordination with the various stakeholders at global, regional, and country levels to ensure successful program implementation.
Author(s): Hajjeh R
Visit web page (English)
(Located at rstb.royalsocietypublishing.org)
Citation: Hajjeh R. Accelerating Introduction of New Vaccines: Barriers to Introduction and Lessons Learned From the Recent Haemophilus influenzae type b Vaccine Experience. Philosophical Transactions of the Royal Society B. 2011;366(1579):2827-2832.